Feedback / Questions
Dyanavel XR (amphetamine XR) - Tris Pharma
https://www.newswire.ca/news-releases/kye-pharmaceuticals-announces-the-approval-of-dyanavel-r-xr-amphetamine-extended-release-tablets-and-oral-suspension-for-the-treatment-of-adults-and-children-with-adhd-868270904.html
Aug 5, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next